Humoral alloimmunity in transplantation: Relevance of HLA epitope antigenicity and immunogenicity

Frontiers in Immunology

Volumn 2, Issue NOV, 2011, Pages

  Duquesnoy, René J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Eplet; HLA antibody; HLA epitope; Hlamatchmaker; Non self self paradigm of HLA epitope

Indexed keywords

EID: 84857111855     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00059     Document Type: Article

References (43)

1. Chothia, C., and Lesk, A. (1987). Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 196, 901-917.
2. Claas, F. H., Gijbels, Y., von Veen, A., de Waal, L. P., D'Amaro, J., Persijn, G. G., and van Rood, J. J. (1989). Selection of cross-match negative HLAA and/or -B mismatched donors for highly sensitized patients. Transplant. Proc. 21, 665-666.
3. Claas, F. H. J., Dankers, M. K., Oudshoorn, M., van Rood, J. J., Mulder, A., Roelen, D. L., Duquesnoy, R. J., and Doxiadis, I. I. N. (2005). Differential immunogenicity of HLA mismatches in clinical transplantation. Transpl. Immunol. 14, 187-191.
4. Claas, F. H. J., Witvliet, M., Duquesnoy, R. J., Persijn, G., and Doxiadis, I. I. N. (2004). The acceptable mismatch program as a fast tool to transplant highly sensitized patients awaiting a post-mortal kidney: short waiting time and excellent graft outcome. Transplantation 78, 190-193.
5. Dankers, M. K. A., Witvliet, M. D., Roelen, D. L., De Lange, P., Korfage, N., Persijn,G. G.,Duquesnoy,R. J.,Doxiadis, I. I. N., and Claas, F. H. J. (2004). The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched HLA antigens. Transplantation 128, 1236-1239.
6. Davies, D., Padlan, E., and Sheriff, S. (1990). Antibody-antigen complexes. Annu. Rev. Biochem. 59, 439-473.
7. Doxiadis, I. I. N., Duquesnoy, R. J., and Claas, F. H. J. (2005). Extending options for highly sensitized patients to receive a suitable kidney graft. Curr. Opin. Immunol. 17, 536-540.
8. Duquesnoy, R. (2008a). Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Curr. Opin. Immunol. 20, 594-601.
9. Duquesnoy, R. (2008b). HLA class II antibodies and transplant outcome (invited editorial). Transplantation 86, 638-640.
10. Duquesnoy, R. (2011a). Antibodyreactive epitope determination with HLAMatchmaker and its application in transplantation. Tissue Antigens 77, 525-534.
11. Duquesnoy, R. (2011b). The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity. Int. J. Immunogenet. doi: 10.1111/j.1744313X.2011.01042.x. [Epub ahead of print].
12. Duquesnoy, R., and Marrari, M. (2011). Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants. Transpl. Immunol. 24, 164-171.
13. Duquesnoy, R., Mostecki, J., Hariharan, J., and Balasz, I. (2008a). A structurally based epitope analysis of MICA antibody specificity patterns. Hum. Immunol. 69, 826-832.
14. Duquesnoy, R., Awadalla, Y., Lomago, J., Jelinek, L., Howe, J., Zern, D., Hunter, B., Martell, J., Girnita, A., and Zeevi, A. (2008b). Retransplant candidates have donorspecific antibodies that react with structurally defined HLA-DR, DQ, DP epitopes. Transpl. Immunol. 18, 352-360.
15. Duquesnoy, R. J. (2002). HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum. Immunol. 63, 339-352.
16. Duquesnoy, R. J. (2006). A structurally based approach to determine HLA compatibility at the humoral immune level. Hum. Immunol. 67, 847-862.
17. Duquesnoy, R. J., and Askar, M. (2007). HLAMatchmaker: a molecularly based algorithm for histocompatibility determinationV. Eplet matching for HLA-DR, HLA-DQ and HLA-DP. Hum. Immunol. 68, 12-25.
18. Duquesnoy, R. J., and Marrari, M. (2009). HLAMatchmaker-based definition of structural HLA epitopes detected by alloantibodies. Curr. Opin. Organ Transplant. 14, 403-409.
19. Duquesnoy, R. J., Mulder, A., Askar, M., Fernandez-Vina, M., and Claas, F. H. J. (2005). HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum. Immunol. 66, 749-761.
20. Duquesnoy, R. J., White, L. T., Fierst, J. W., Vanek, M., Banner, B. F., Iwaki, Y., and Starzl, T. E. (1990). Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation. Transplantation 50, 427-437.
21. Duquesnoy, R. J., Witvliet, M. J., Doxiadis, I. I. N., de Fijter, H., and Claas, F. H. J. (2004). HLAMatchmakerbased strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates. Transpl. Int. 7, 31-38.
22. Getzoff, E. D., Tainer, J. A., Lerner, R. A., and Geysen, H. M. (1988). The chemistry and mechanisnm of antibody binding to protein antigens. Adv. Immunol. 43, 1-98.
23. Goodman, R., Taylor, C., O'Rourke, C., Lynch, A., Bradley, A., and Key, K. (2006). Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitised patients awaiting kidney transplantation. Transplantation 81, 1331-1336.
24. Hogue, C. (1997). Cn3D: a new generation of three-dimensional molecular structure viewer. Trends Biochem. Sci. 22, 314-316.
25. Hulsmeyer, M., Chames, P., Hillig, R., Stanfield, R., Held, G., Coulie, P., Alings, C., Wille, G., Saenger, W., Uchanska-Ziegler, B., Hoogenboom, H., and Ziegler, A. (2005). A major histocompatibility complexpeptide-restricted antibody and T cell receptor molecules recognize their target by distinct binding modes. Crystal structure of human leukocyte antigen (HLA)-A1 -MAGE-A1 complex with Fab-Hyb3. J. Biol. Chem. 280, 2972-2980.
26. Kabat, E. A., Wu, T., and Bilofsky, H. (1977). Unusual distribution of amino acids in complementaritydetermining (hypervarible) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites. J. Biol. Chem. 252, 6609-6617.
27. Kosmoliaptsis, V., Bradley, J., Sharples, L., Chaudhry, A., Key, T., Goodman, R., and Taylor, C. (2008). Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. Transplantation 85, 1817-1825.
28. Kuroda, D., Shirai, H., Kobori, M., and Nakamura, H. (2009). Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface. Proteins 75, 139-146.
29. Laune, D., Molina, K., Ferrieres, G., Mani, J.-C., Cohen, P., Simon, D., Bernardi, T., Piechaczyk, M., Pau, B., and Granier, C. (1997). Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins. J. Biol. Chem. 272, 30937-30944.
30. *4402? Hum. Immunol. 71, 176-178.
31. MacCallum, R. M., Martin,A. C. R., and Thornton, J. M. (1996). Antibodyantigen interactions: contact analysis and binding site topography. J. Mol. Biol. 262, 732-745.
32. Marrari,M.,Conca,R.,Praticò-Barbato, L., Amoroso, A., and Duquesnoy, R. (2011). Brief report: why did two patients who type for HLA-B13 have antibodies that react with All Bw4 antigens except HLA-B13? Transpl. Immunol. 25, 217-220.
33. Marrari, M., and Duquesnoy, R. (2009). Why can sensitization by a HLADR2 mismatch lead to antibodies that react also with HLA-DR1? Hum. Immunol. 70, 403-409.
34. Marrari, M., Mostecki, J., Mulder, A., Balazs, I., Claas, F., and Duquesnoy, R. (2010). Human monoclonal antibody reactivity with HLA class I epitopes defined by pairs of mismatched eplets and self eplets. Transplantation 90, 1468-1472.
35. Mihaylova, A., Baltadjieva, D., Boneva, P., Ivanova, M., Penkova, K., Marinova, D., Mihailova, S., Paskalev, E., Simeonov, P., and Naumova, E. (2006). Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays - single-center experience. Hum. Immunol. 67, 787-794.
36. Novotny, J. (1991). Protein antigenicity: a thermodynamic approach. Mol. Immunol. 28, 201-208.
37. Padlan, E. A. (1994). Anatomy of the antibody molecule. Mol. Immunol. 31, 169-217.
38. Poljak, R., Amzel, L., Avey, H., Chen, B., Phizackerley, R., and Saul, F. (1973). Three-dimensional structure of the Fab' fragment of a human immunoglobulin at 2,8-A resolution. Proc. Natl. Acad. Sci. U.S.A. 70, 3305-3310.
39. Rodey, G. E., Neylan, J. F., Whelchel, J. D., Revels, K. W., and Bray, R. A. (1994). Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum. Immunol. 39, 272-280.
40. Shirai, H., Kidera, A., and Nakamura, H. (1999). H3-rules: identification of CDR-H3 structures in antibodies. FEBS Lett. 455, 188-197.
41. Tambur, A., Leventhal, J. R., Friedewald, J., and Ramon, D. (2010). The complexity of human leukocyte antigen (HLA)-DQ antibodies and its effect on virtual crossmatching. Transplantation 90, 1117-1124.
42. Van Regenmortel, M. (2002). Reductionism and the search for structure-function relationships in antibody molecules. J. Mol. Recognit. 15, 240-247.
43. Wu, T., Johnson, G., and Kabat, E. (1993). Length distribution of CDRH3 in antibodies. Proteins 16, 1-7.